Ashley Magargee
Ashley Magargee is the CEO of Genentech, part of the Roche Group, which is a leading biotechnology company. She was featured in the news for announcing a significant $50 billion commitment to biotech manufacturing and research during a White House event.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Switzerland | 1 | 7.00 | 0.17% | +0% | 8,654,622 | 14,376 | $700,000 | 1,163$ |
| Totals | 1 | 8,654,622 | 14,376 | $700,000 | 1,163$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Switzerland:
Ashley Magargee is the CEO of Genentech, a subsidiary of Roche, involved in the drug pricing agreement with the US government.
7
Switzerland:
Ashley Magargee, CEO of Genentech, was present at the announcement of a deal with the U.S. government regarding drug prices.
6
Switzerland:
Ashley Magargee is the CEO of Genentech, the American subsidiary of Roche, and was present during the announcement of a deal with the U.S. government.
6
Switzerland:
Ashley Magargee, CEO of the American Roche subsidiary Genentech, was present at the announcement in the White House.
7
Switzerland:
Ashley Magargee, CEO of Genentech, represented Roche at the announcement of drug pricing agreements.
6
Switzerland:
Ashley Magargee is the CEO of Genentech, a subsidiary of Roche, who was present during the announcement at the White House.
6
Switzerland:
Ashley Magargee is the head of Genentech, the American subsidiary of Roche.
5
United States:
Genentech, led by Ashley Magargee, announced a massive $50 billion commitment to biotech manufacturing and research.
8